Markus Puhlmann
Chief Tech/Sci/R&D Officer at PERSPECTIVE THERAPEUTICS, INC.
Net worth: 2 M $ as of 2024-04-29
Markus Puhlmann active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Markus Puhlmann
Former positions of Markus Puhlmann
| Companies | Position | Start | End |
|---|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | 2018-12-31 | 2021-12-31 |
| MERCK & CO., INC. | Corporate Officer/Principal | 2014-12-31 | 2018-12-31 |
Training of Markus Puhlmann
| Ludwig-Maximilians-Universität München | Doctorate Degree |
| McDonough School of Business | Masters Business Admin |
Statistics
International
| United States | 4 |
| 2 | |
| Germany | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Private companies | 2 |
|---|---|
| Perspective Therapeutics, Inc. | |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Stock Market
- Insiders
- Markus Puhlmann
- Experience
